```html

Yellow‑Bellied Sea Snake Envenomation

Overview

The yellow‑bellied sea snake (Hydrophis platurus, also called the pelagic sea snake) is a highly venomous elapid that spends its entire life in open ocean waters. Envenomation occurs when a person is bitten, most often while fishing, diving, or handling caught snakes. Although bites are rare—estimated at fewer than 10 cases per year worldwide—they can be life‑threatening because the snake’s venom contains potent neurotoxins and myotoxins.

Who it affects: Anyone who comes into direct contact with a live snake—fishers, marine biologists, snorkelers, or tourists who accidentally capture the animal—can be bitten. The majority of reported cases involve adult males engaged in commercial or recreational fishing in the Indo‑Pacific region.

Prevalence: The International Society of Snakebite Professionals (ISSP) reports that sea‑snake bites represent < 1 % of all snake‑bite encounters worldwide, with the highest incidence in coastal areas of Australia, Indonesia, the Philippines, and Malaysia. Because the snakes are fast swimmers and bites often occur far from medical facilities, the true global burden may be under‑reported (World Health Organization, 2022).

Symptoms

Symptoms develop rapidly—often within minutes—and can progress from mild local effects to severe systemic toxicity. The clinical picture may vary depending on the amount of venom injected and the victim’s age, size, and overall health.

Local Findings

• Immediate pain at the bite site, described as sharp or burning.
• Erythema (redness) and edema (swelling) that may spread proximally.
• Ecchymosis (bruising) or purpura if bleeding occurs.
• Necrosis (tissue death) is uncommon but can develop with delayed treatment.

Neurologic Signs

• Paresthesia (tingling) or numbness radiating from the bite.
• Muscle weakness – begins in the facial muscles and progresses to the limbs.
• Ptosis (drooping eyelids) and ophthalmoplegia (difficulty moving eyes).
• Swallowing difficulty and speech changes (dysarthria).
• Respiratory paralysis – can lead to respiratory failure within 30–60 minutes of a severe bite.

Cardiovascular & Systemic Effects

• Hypotension (low blood pressure) due to vasodilation.
• Bradycardia (slow heart rate) or, less commonly, tachycardia.
• Hematuria (blood in urine) indicating renal involvement.
• Coagulopathy – prolonged clotting times; occasional bleeding from gums or IV sites.
• Myalgia and rhabdomyolysis (muscle breakdown) may cause dark urine and risk of acute kidney injury.

Delayed or Rare Manifestations

• Serum sickness–like reaction (fever, rash, arthralgia) 5–10 days after the bite.
• Permanent neurological deficits if respiratory paralysis is prolonged.

Causes and Risk Factors

Envenomation is caused by the injection of venom from the snake’s hollow fangs during a bite. The venom is a complex mixture of neurotoxins (e.g., alpha‑bungarotoxin), myotoxins, and enzymes that disrupt neuromuscular transmission, muscle integrity, and coagulation pathways.

Primary Causes

• Direct bite while handling a live snake.
• Accidental contact when a snake is trapped in nets, lines, or fishing gear.
• Defensive bite if a snake feels threatened.

Risk Factors

• Occupational exposure: Commercial fishermen, shrimp trawlers, or marine researchers.
• Recreational activities: Spearfishing, snorkeling, or sea‑snake watching tours.
• Geographic location: Coastal waters of the Indo‑Pacific, especially around coral reefs and mangroves where the snakes congregate.
• Lack of protective equipment: Bare hands or inadequate gloves when handling catch.
• Delayed access to medical care: Bites occurring far from hospitals increase risk of severe outcomes.

Diagnosis

Rapid recognition is essential. Diagnosis is clinical, supported by laboratory and imaging studies.

Clinical Assessment

• Detailed history of the bite (time, location, appearance of the snake if known).
• Physical exam focusing on neuro‑muscular function, respiratory status, and local wound.

Laboratory Tests

• Complete blood count (CBC) – may show leukocytosis or anemia from hemolysis.
• Coagulation panel (PT, aPTT, INR) – to detect venom‑induced coagulopathy.
• Creatine kinase (CK) – elevated in rhabdomyolysis.
• Serum electrolytes & renal function – monitor for acute kidney injury.
• Venom‑specific ELISA – available in specialized centers (e.g., Australian Snake Bite Centre) but not required for acute management.

Imaging

• Chest X‑ray – assess for pulmonary infiltrates if respiratory distress develops.
• Ultrasound of the bite site – can identify deep tissue fluid collections.

Differential Diagnosis

Other marine envenomations (jellyfish, stonefish), bacterial infections, or allergic reactions should be considered.

Treatment Options

Management follows a stepwise approach: first‑aid measures, antivenom administration, supportive care, and monitoring for complications.

First‑Aid (Pre‑Hospital)

• Call emergency medical services immediately.
• Keep the victim still; limit movement to slow venom spread.
• Apply a pressure immobilization bandage (firm but not constrictive) from the bite upward.
• Do not apply tourniquets, cut the wound, or attempt suction.
• Monitor vital signs and be prepared for cardiopulmonary resuscitation.

Antivenom

The mainstay of therapy is the Australian Sea‑Snake Antivenom (often a polyvalent elapid antivenom). Dosage guidelines (based on WHO recommendations):

• Initial dose: 10 vials IV over 30 minutes.
• Repeat doses every 6 hours if neuro‑toxic signs persist, up to a total of 30 vials.
• Premedication with antihistamines (e.g., diphenhydramine 50 mg IV) and corticosteroids (e.g., hydrocortisone 100 mg IV) may reduce serum‑sickness reactions.

In regions without specific sea‑snake antivenom, a polyvalent elapid antivenom may be used under expert guidance.

Supportive Care

• Airway & breathing: Intubate and mechanically ventilate if respiratory muscle weakness occurs.
• Fluid resuscitation: Maintain euvolemia; avoid hypotonic fluids if rhabdomyolysis is present.
• Renal protection: Alkalinize urine with sodium bicarbonate (if CK > 5,000 U/L) and monitor urine output.
• Pain control: IV opioids (e.g., morphine) for severe pain; avoid NSAIDs if coagulopathy is present.
• Antibiotics: Not routine; indicated only for secondary infection.

Adjunct Therapies

• Anticholinesterase agents (e.g., neostigmine 0.05 mg/kg IV) may temporarily improve neuromuscular transmission in mild cases, but evidence is limited.
• Plasma exchange or dialysis in severe rhabdomyolysis with renal failure.

Rehabilitation & Follow‑up

• Physiotherapy to restore muscle strength after prolonged ventilation.
• Neuro‑psychological assessment if prolonged ICU stay.
• Serial labs for CK, renal function, and coagulation for at least 72 hours.

Living with Yellow‑Bellied Sea Snake Envenomation

Even after successful treatment, some patients experience lingering effects. The following tips help with long‑term recovery.

Physical Health

• Gradual return to activity; avoid heavy lifting for 2–4 weeks if muscle weakness persisted.
• Stay hydrated; monitor urine color for signs of myoglobinuria.
• Continue physiotherapy to regain full range of motion.

Psychological Well‑Being

• Post‑traumatic stress disorder (PTSD) is reported in 10–15 % of severe envenomation survivors (Cleveland Clinic, 2021). Consider counseling.
• Join support groups for marine‑life workers; shared experiences aid coping.

Medical Follow‑up

• Visit your primary care physician or a tropical medicine specialist within 1 week of discharge.
• Repeat renal function tests at 1 month and 3 months if CK was markedly elevated.
• Vaccinate against tetanus if not up‑to‑date (standard 10‑year booster).

Prevention

Because bites are rare but potentially fatal, prevention focuses on education and protective practices.

• Wear appropriate gloves (heavy‑duty neoprene or leather) when handling nets, lines, or caught fish.
• Use protective netting on boat decks to prevent snakes from slipping into gear.
• Educate crew members on how to identify sea snakes—yellow‑bellied sea snakes have a distinctive bright yellow under‑belly and a dark dorsal pattern.
• Implement first‑aid training on pressure immobilization bandaging for all personnel on vessels operating in endemic areas.
• Maintain a well‑stocked medical kit on board, including antivenom (where regulations permit) and emergency airway equipment.
• Report any snake sightings to local marine authorities; avoid attempting to capture or move them.

Complications

If antivenom is delayed or supportive care is insufficient, several serious complications can develop.

• Respiratory failure – the leading cause of death; may require prolonged mechanical ventilation.
• Acute kidney injury from myoglobinuria; 5–10 % of severe cases need dialysis.
• Coagulopathy and bleeding – can lead to intracranial hemorrhage or gastrointestinal bleeding.
• Permanent neuromuscular deficits – persistent weakness or paralysis of limbs.
• Secondary infections at the bite site, especially in tropical environments.
• Serum sickness (fever, rash, arthralgia) 5–10 days after antivenom administration; treat with corticosteroids.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH (NIH Toxicology Data Network), World Health Organization, Cleveland Clinic, Australian Snake Bite Centre, International Society of Snakebite Professionals (2023‑2024 data).

```